[Treatment of chronically recurring urinary tract infection with trimethoprim sulfamethoxazole (Eusaprim)].
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis / Q000150:complications; D011743:Pyrimidines / Q000627:therapeutic use*; D012008:Recurrence; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D014295:Trimethoprim / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology; D014556:Urine / Q000032:analysis / Q000382:microbiology
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Zur Behandlung des chronisch-rezidivierenden Harnweginfekts mit Trimethoprim-Sulfamethoxazol (Eusaprim.